China Medical Digital Imaging System Market Report 2023 to 2030

China Medical Digital Imaging System Market Analysis

$ 3999

The China Medical Digital Imaging System Market was valued at $2451.81 Mn in 2023 and is predicted to grow at a CAGR of 9.7% from 2023 to 2030, to $4687.42 Mn by 2030. The key drivers of this industry include increasing healthcare spending, rising chronic disease, and the aging population. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.

ID: IN10CNDH156 CATEGORY: Digital Health GEOGRAPHY: China AUTHOR: Aashwi Mehta

Buy Now

China Medical Digital Imaging System Market Executive Summary

The China Medical Digital Imaging System Market was valued at $2451.81 Mn in 2023 and is predicted to grow at a CAGR of 9.7% from 2023 to 2030, to $4687.42 Mn by 2030.

Medical digital imaging systems comprise various technologies employed in healthcare to create visual representations of the body's internal structures for clinical analysis and medical interventions. These systems have evolved considerably and are crucial in contemporary medicine, assisting in the diagnosis and treatment of diseases. Medical imaging encompasses ultrasound, x-rays, computed tomography (CT scans), Magnetic Resonance Imaging (MRI), and nuclear medicine technologies.

In China, among the diagnostic radiology equipment, general diagnostic radiology accounted for the highest proportion of units at 50.31%. The proportions of other equipment, from high to low, included equipment for dental radiology (17.15%), CT (14.13%), fluoroscopy (13.15%), mammography (2.80%), and tests of bone mineral density (2.46%). The market is driven by significant factors like increasing healthcare spending, rising chronic disease, and the aging population. However, high costs, lack of skilled professionals, and regulatory challenges restrict the growth and potential of the market.

Prominent players in this field include Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.

China Medical Digital Imaging System Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Increasing Healthcare Spending: China's current health expenditure of 5.38% of GDP in 2021 drives the medical digital imaging system market by demonstrating a strong financial commitment to healthcare improvement. This significant investment supports the adoption of advanced imaging technologies, enhances diagnostic capabilities, and improves access to quality healthcare services.

Rising Chronic Disease: The high prevalence of chronic diseases, affecting 81.1% of Chinese older adults and representing 179.9 Mn individuals, is a crucial market driver for the medical digital imaging system market in China. This widespread incidence of chronic conditions necessitates frequent and accurate diagnostic imaging to manage and monitor these diseases effectively, driving the demand for medical digital imaging systems.

Aging Population: The projected increase to 402 Mn people over the age of 60 by 2040, constituting 28% of China's total population, is a significant market driver for medical digital imaging systems. An aging population will lead to a higher prevalence of age-related and chronic conditions, necessitating frequent and advanced diagnostic imaging for effective healthcare management.

Market Restraints

High Cost: Maintaining imaging systems can be excessively costly, particularly for smaller healthcare organizations with constrained resources. This financial barrier restricts their ability to acquire and incorporate new imaging technology, thereby constraining market growth.

Lack of Skilled Professionals: The shortage of radiologists in China, with one radiologist per 70,000 individuals handling an excessive daily workload, limits the effective use of digital imaging systems and hinders the adoption of advanced technologies, impacting the market growth.

Regulatory Challenges: The market for medical digital imaging systems in China is severely constrained by regulatory issues because of the difficult and rigorous approval procedures needed to introduce new technology. Adoption and technological advancement of new medical digital imaging systems are hindered, leading to delays and higher prices.

Regulatory Landscape and Reimbursement Scenario

The National Medical Products Administration (NMPA), previously known as the China Food and Drug Administration (CFDA), is the Chinese authority responsible for regulating drugs and medical devices. The Regulation on the Supervision and Administration of Medical Devices by the State Council introduces a category-based administration of medical devices according to the level of risk wherein all products should satisfy the national compulsory standards for medical devices. In China, reimbursement for medical digital imaging systems is governed by a complex framework involving the National Development and Reform Commission (NDRC), the Ministry of Health (MOH), and provincial health bureaus. Rates vary significantly between provinces and cities, even for the same procedures.

Competitive Landscape

Key Players

Here are some of the major key players in the China Medical Digital Imaging System Market:

Siemens Healthineers
GE Healthcare
Philips Healthcare
Canon Medical Systems
Mindray
Fujifilm
Shimadzu
Konica Minolta
Hologic
Esaote

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

China Medical Digital Imaging System Market Segmentation

By Type

X-Ray
MRI
CT scan
Ultrasound
Others

By Technology

2D Imaging System
3D/4D Imaging System

By Application

Orthopedics
Oncology
Cardiology
Neurology
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.